Chronically elevated corticosterone in the dorsolateral bed nuclei of stria terminalis increases anxiety-like behavior

Behavioural Brain Research

Volumn 203, Issue 1, 2009, Pages 146-149

  Shepard, Jack D ^a   Chambers, Charles O ^a   Busch, Chris ^a   Mount, Alexander ^a   Schulkin, Jay ^b,c,d  

^a TOWSON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; Bed nuclei of stria terminalis; BNST; BST; Corticosterone; Extended amygdala; Fear; Glucocorticoids

Indexed keywords

CORTICOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HORMONE DETERMINATION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; STRIA TERMINALIS;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; CHOLESTEROL; CORTICOSTERONE; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; RATS; RATS, WISTAR; SEPTAL NUCLEI; TIME FACTORS;

EID: 67349143417     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.04.029     Document Type: Article

References (33)

1. Adamec R., Kent P., Anisman H., Shallow T., and Merali Z. Neural plasticity, neuropeptides and anxiety in animals-implications for understanding and treating affective disorder following traumatic stress in humans. Neurosci Biobehav Rev 23 (1998) 301-318
2. Calvo N., Martijena I.D., Molina V.A., and Volosin M. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress. Brain Res 800 (1998) 227-235
3. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
4. Cook C.J. Glucocorticoid feedback increases the sensitivity of the limbic system to stress. Physiol Behav 75 (2002) 455-464
5. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
6. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety?. Biol Psychiatry 44 (1998) 1239-1247
7. Dong H.W., Petrovich G.D., and Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38 (2001) 192-246
8. Gray T.S. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 697 (1993) 53-60
9. Greenwood-Van M.B., Gibson M., Gunter W., Shepard J.D., Foreman R., and Myers D.A. Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res 893 (2001) 135-142
10. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 25 (2001) 117-142
11. Korte S.M., and De Boer S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463 (2003) 163-175
12. Makino S., Gold P.W., and Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657 (1994) 141-149
13. Myers B., Dittmeyer K., and Greenwood-Van M.B. Involvement of amygdaloid corticosterone in altered visceral and somatic sensation. Behav Brain Res 181 (2007) 163-167
14. Myers B., and Greenwood-Van M.B. Corticosteroid-receptor mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 292 (2007) G1622-G1629
15. Myers D.A., Gibson M., Schulkin J., and Greenwood Van-Meerveld B. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 161 (2005) 39-44
16. Pego J.M., Morgado P., Pinto L.G., Cerqueira J.J., Almeida O.F., and Sousa N. Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 27 (2008) 1503-1516
17. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
18. Pereira L.O., da C.I., Neto J.M., Paschoalini M.A., and Faria M.S. The gradient of luminosity between open/enclosed arms, and not the absolute level of Lux, predicts the behaviour of rats in the plus maze. Behav Brain Res 159 (2005) 55-61
19. Pugh C.R., Tremblay D., Fleshner M., and Rudy J.W. A selective role for corticosterone in contextual-fear conditioning. Behav Neurosci 111 (1997) 503-511
20. Rosen J.B., Donley M.P., Gray D., West E.A., Morgan M.A., and Schulkin J. Chronic corticosterone administration does not potentiate unconditioned freezing to the predator odor, trimethylthiazoline. Behav Brain Res 194 (2008) 32-38
21. Rosen J.B., and Schulkin J. From normal fear to pathological anxiety. Psychol Rev 105 (1998) 325-350
22. Sakanaka M., Shibasaki T., and Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382 (1986) 213-238
23. Schulkin J., McEwen B.S., and Gold P.W. Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 18 (1994) 385-396
24. Schulkin J., Morgan M.A., and Rosen J.B. A neuroendocrine mechanism for sustaining fear. Trends Neurosci 28 (2005) 629-635
25. Shepard J.D., Barron K.W., and Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861 (2000) 288-295
26. Shepard J.D., Barron K.W., and Myers D.A. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 963 (2003) 203-213
27. Shepard J.D., Schulkin J., and Myers D.A. Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Behav Brain Res 174 (2006) 193-196
28. Skorzewska A., Bidzinski A., Lehner M., Turzynska D., Wislowska-Stanek A., Sobolewska A., et al. The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures. Pharmacol Biochem Behav 85 (2006) 522-534
29. Swanson L.W., and Simmons D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 285 (1989) 413-435
30. Thompson B.L., Erickson K., Schulkin J., and Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res 149 (2004) 209-215
31. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44 (1993) 463-469
32. Walker D.L., and Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct 213 (2008) 29-42
33. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 (2003) 199-216